| MeSH term | MeSH ID | Detail |
|---|---|---|
| Vestibulocochlear Nerve Diseases | D000160 | 1 associated lipids |
| Acromegaly | D000172 | 6 associated lipids |
| Actinobacillus Infections | D000189 | 4 associated lipids |
| Actinomycosis | D000196 | 2 associated lipids |
| Addison Disease | D000224 | 3 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Adrenal Hyperplasia, Congenital | D000312 | 2 associated lipids |
| Albuminuria | D000419 | 18 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Angina, Unstable | D000789 | 14 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Liu JZ et al. | [Expression of human osteoprotegerin gene in E. Coli and bioactivity analysis of expression product]. | 2003 | Zhonghua Wai Ke Za Zhi | pmid:14680558 |
| Yamada Y et al. | Association of polymorphisms of the osteoprotegerin gene with bone mineral density in Japanese women but not men. | 2003 | Mol. Genet. Metab. | pmid:14680982 |
| Schett G et al. | The role of osteoprotegerin in arthritis. | 2003 | Arthritis Res. Ther. | pmid:12932284 |
| Stilgren LS et al. | Osteoprotegerin levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism. | 2003 | Calcif. Tissue Int. | pmid:14667132 |
| Karsdal MA et al. | Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression. | 2003 | J. Biol. Chem. | pmid:12933809 |
| Okada T et al. | Bone marrow metastatic myeloma cells promote osteoclastogenesis through RANKL on endothelial cells. | 2003 | Clin. Exp. Metastasis | pmid:14669795 |
| Benevolenskaia LI | [Issues of osteoporosis in present-day medicine]. | 2003 | Vestn. Akad. Med. Nauk SSSR | pmid:12934464 |
| Gannagé-Yared MH et al. | Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy post-menopausal women. | 2003 | J. Endocrinol. Invest. | pmid:14669830 |
| Sugatani T et al. | Activin A stimulates IkappaB-alpha/NFkappaB and RANK expression for osteoclast differentiation, but not AKT survival pathway in osteoclast precursors. | 2003 | J. Cell. Biochem. | pmid:12938156 |
| Ashcroft AJ et al. | Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin. | 2003 | Immunity | pmid:14670302 |
| Min JK et al. | Vascular endothelial growth factor up-regulates expression of receptor activator of NF-kappa B (RANK) in endothelial cells. Concomitant increase of angiogenic responses to RANK ligand. | 2003 | J. Biol. Chem. | pmid:12893832 |
| Chong B et al. | Idiopathic hyperphosphatasia and TNFRSF11B mutations: relationships between phenotype and genotype. | 2003 | J. Bone Miner. Res. | pmid:14672344 |
| Teitelbaum SL and Ross FP | Genetic regulation of osteoclast development and function. | 2003 | Nat. Rev. Genet. | pmid:12897775 |
| Nielsen KL et al. | Biglycan deficiency interferes with ovariectomy-induced bone loss. | 2003 | J. Bone Miner. Res. | pmid:14672350 |
| Si AI et al. | Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone. | 2003 | J. Cell. Biochem. | pmid:12898514 |
| Nitta K et al. | The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis. | 2003 | Am. J. Kidney Dis. | pmid:12900812 |
| Amizuka N et al. | Defective bone remodelling in osteoprotegerin-deficient mice. | 2003 | J Electron Microsc (Tokyo) | pmid:14756238 |
| Fizazi K et al. | Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts. | 2003 | Clin. Cancer Res. | pmid:12855635 |
| Kawana F and Sasaki T | Osteoclast differentiation and characteristic trabecular bone formation during growth plate destruction in osteoprotegerin-deficient mice. | 2003 | J Electron Microsc (Tokyo) | pmid:14756239 |
| Okuma K et al. | Development of a novel surrogate virus for human T-cell leukemia virus type 1: inhibition of infection by osteoprotegerin. | 2003 | J. Virol. | pmid:12857926 |
| Cheng X et al. | The TNF receptor superfamily: role in immune inflammation and bone formation. | 2003 | Immunol. Res. | pmid:12857975 |
| Shin MM et al. | High extracellular Ca2+ alone stimulates osteoclast formation but inhibits in the presence of other osteoclastogenic factors. | 2003 | Exp. Mol. Med. | pmid:12858015 |
| Gehrke T et al. | Receptor activator of nuclear factor kappaB ligand is expressed in resident and inflammatory cells in aseptic and septic prosthesis loosening. | 2003 | Scand. J. Rheumatol. | pmid:14690142 |
| Glossop JR et al. | No association of polymorphisms in the tumor necrosis factor receptor I and receptor II genes with disease severity in rheumatoid arthritis. | 2003 | J. Rheumatol. | pmid:12858434 |
| Hampson G et al. | Effects of dietary improvement on bone metabolism in elderly underweight women with osteoporosis: a randomised controlled trial. | 2003 | Osteoporos Int | pmid:12904840 |
| Misra M et al. | Serum osteoprotegerin in adolescent girls with anorexia nervosa. | 2003 | J. Clin. Endocrinol. Metab. | pmid:12915674 |
| Lonergan M et al. | Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptors, and the soluble receptor osteoprotegerin in human gestational membranes and amniotic fluid during pregnancy and labor at term and preterm. | 2003 | J. Clin. Endocrinol. Metab. | pmid:12915677 |
| Sezer O et al. | RANK ligand and osteoprotegerin in myeloma bone disease. | 2003 | Blood | pmid:12424190 |
| Yamada T et al. | Regulation of osteoclast development by Notch signaling directed to osteoclast precursors and through stromal cells. | 2003 | Blood | pmid:12411305 |
| Smith MD et al. | Microarchitecture and protective mechanisms in synovial tissue from clinically and arthroscopically normal knee joints. | 2003 | Ann. Rheum. Dis. | pmid:12634226 |
| Sakurai A et al. | Streptococcus pyogenes infection induces septic arthritis with increased production of the receptor activator of the NF-kappaB ligand. | 2003 | Infect. Immun. | pmid:14500523 |
| Kim HH et al. | RANKL regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. | 2003 | FASEB J. | pmid:14500543 |
| Nakamura M et al. | Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption. | 2003 | Endocrinology | pmid:14500574 |
| Zhang Z et al. | Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis. | 2003 | J. Immunol. | pmid:14500659 |
| Ueno Y et al. | In vivo administration of 1,25-dihydroxyvitamin D3 suppresses the expression of RANKL mRNA in bone of thyroparathyroidectomized rats constantly infused with PTH. | 2003 | J. Cell. Biochem. | pmid:14505343 |
| Kaneyama K et al. | Osteoclastogenesis inhibitory factor/osteoprotegerin in synovial fluid from patients with temporomandibular disorders. | 2003 | Int J Oral Maxillofac Surg | pmid:14505625 |
| Grigorie D et al. | Circulating osteoprotegerin and leptin levels in postmenopausal women with and without osteoporosis. | 2003 | Rom J Intern Med | pmid:15526523 |
| Cho TJ et al. | Tumor necrosis factor alpha activation of the apoptotic cascade in murine articular chondrocytes is associated with the induction of metalloproteinases and specific pro-resorptive factors. | 2003 | Arthritis Rheum. | pmid:14558090 |
| von Tirpitz C et al. | Effect of systemic glucocorticoid therapy on bone metabolism and the osteoprotegerin system in patients with active Crohn's disease. | 2003 | Eur J Gastroenterol Hepatol | pmid:14560148 |
| Barillé-Nion S and Bataille R | New insights in myeloma-induced osteolysis. | 2003 | Leuk. Lymphoma | pmid:14565645 |
| Kudlacek S et al. | Serum levels of osteoprotegerin increase with age in a healthy adult population. | 2003 | Bone | pmid:12810175 |
| Mandelin J et al. | Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement. | 2003 | J Bone Joint Surg Br | pmid:14653607 |
| Ikeda T et al. | Hepatocellular carcinoma with osteoclast-like giant cells: possibility of osteoclastogenesis by hepatocyte-derived cells. | 2003 | Pathol. Int. | pmid:12828610 |
| Malyszko J et al. | Osteoprotegerin and its correlations with new markers of bone formation and bone resorption in kidney transplant recipients. | 2003 | Transplant. Proc. | pmid:14529897 |
| Crotti T et al. | Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. | 2003 | J. Periodont. Res. | pmid:12828654 |
| Ren W et al. | Distinct gene expression of receptor activator of nuclear factor-kappaB and rank ligand in the inflammatory response to variant morphologies of UHMWPE particles. | 2003 | Biomaterials | pmid:14530078 |
| Tazoe M et al. | Involvement of p38MAP kinase in bone morphogenetic protein-4-induced osteoprotegerin in mouse bone-marrow-derived stromal cells. | 2003 | Arch. Oral Biol. | pmid:12828991 |
| Wiethe C et al. | Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B (RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen. | 2003 | J. Immunol. | pmid:14530334 |
| Wiethe C et al. | Provision of 4-1BB ligand enhances effector and memory CTL responses generated by immunization with dendritic cells expressing a human tumor-associated antigen. | 2003 | J. Immunol. | pmid:12626542 |
| Wagner EF and Matsuo K | Signalling in osteoclasts and the role of Fos/AP1 proteins. | 2003 | Ann. Rheum. Dis. | pmid:14532157 |
| Ueland T et al. | Age-related changes in cortical bone content of insulin-like growth factor binding protein (IGFBP)-3, IGFBP-5, osteoprotegerin, and calcium in postmenopausal osteoporosis: a cross-sectional study. | 2003 | J. Clin. Endocrinol. Metab. | pmid:12629078 |
| Ueland T et al. | Growth hormone substitution increases gene expression of members of the IGF family in cortical bone from women with adult onset growth hormone deficiency--relationship with bone turn-over. | 2003 | Bone | pmid:14555269 |
| Schoppet M et al. | Increased osteoprotegerin serum levels in men with coronary artery disease. | 2003 | J. Clin. Endocrinol. Metab. | pmid:12629080 |
| Nagata N et al. | Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-gamma possibly induced from non-T cell population. | 2003 | Bone | pmid:14555278 |
| Han W et al. | Construction of a new tumour necrosis factor fusion-protein expression vector for high-level expression of heterologous genes in Escherichia coli. | 2003 | Biotechnol. Appl. Biochem. | pmid:12630898 |
| Koshihara Y et al. | Vitamin K stimulates osteoblastogenesis and inhibits osteoclastogenesis in human bone marrow cell culture. | 2003 | J. Endocrinol. | pmid:12630919 |
| Grimaud E et al. | Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis. | 2003 | Am. J. Pathol. | pmid:14578201 |
| Alvarez L et al. | Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates. | 2003 | Arthritis Rheum. | pmid:12632438 |
| Bord S et al. | The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. | 2003 | Bone | pmid:12633785 |
| Coen G et al. | Serum leptin in dialysis renal osteodystrophy. | 2003 | Am. J. Kidney Dis. | pmid:14582047 |
| Garber K | Why it hurts: researchers seek mechanisms of cancer pain. | 2003 | J. Natl. Cancer Inst. | pmid:12783923 |
| Chagraoui H et al. | Expression of osteoprotegerin mRNA and protein in murine megakaryocytes. | 2003 | Exp. Hematol. | pmid:14585373 |
| Liu B et al. | Multinucleated giant cells in various forms of giant cell containing lesions of the jaws express features of osteoclasts. | 2003 | J. Oral Pathol. Med. | pmid:12787044 |
| Eaton CL and Coleman RE | Pathophysiology of bone metastases from prostate cancer and the role of bisphosphonates in treatment. | 2003 | Cancer Treat. Rev. | pmid:12787713 |
| Fahrleitner-Pammer A et al. | Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status. | 2003 | Wien. Klin. Wochenschr. | pmid:12793029 |
| Viereck V et al. | Raloxifene concurrently stimulates osteoprotegerin and inhibits interleukin-6 production by human trabecular osteoblasts. | 2003 | J. Clin. Endocrinol. Metab. | pmid:12970288 |
| Yamagami H et al. | Inhibition of osteoclastogenesis by a phosphodiesterase 4 inhibitor XT-611 through synergistic action with endogenous prostaglandin E2. | 2003 | Biochem. Pharmacol. | pmid:12948861 |
| Srivastava S et al. | Receptor activator of NF-kappaB ligand induction via Jak2 and Stat5a in mammary epithelial cells. | 2003 | J. Biol. Chem. | pmid:12952963 |
| Lee HA et al. | Bumetanide, the specific inhibitor of Na+-K+-2Cl- cotransport, inhibits 1alpha,25-dihydroxyvitamin D3-induced osteoclastogenesis in a mouse co-culture system. | 2003 | Exp. Physiol. | pmid:12955156 |
| Yorke R et al. | Receptor activator of nuclear factor kappaB (RANK) is expressed as a late event during malignant progression in Barrett's metaplasia. | 2003 | Eur. J. Cancer | pmid:12957466 |
| Kaneyama K et al. | Expression of osteoprotegerin in synovial tissue and degradation of articular cartilage: comparison with arthroscopic findings of temporomandibular joint disorders. | 2003 | Oral Surg Oral Med Oral Pathol Oral Radiol Endod | pmid:12973279 |
| Lee ZH and Kim HH | Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. | 2003 | Biochem. Biophys. Res. Commun. | pmid:12745060 |
| Boyle WJ et al. | Osteoclast differentiation and activation. | 2003 | Nature | pmid:12748652 |
| Terpos E et al. | Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index. | 2003 | Blood | pmid:12689925 |
| Zheng B et al. | MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival. | 2003 | Blood | pmid:12689928 |
| Moreno JL et al. | IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKL. | 2003 | Blood | pmid:12689929 |
| Dovio A et al. | Autocrine down-regulation of glucocorticoid receptors by interleukin-11 in human osteoblast-like cell lines. | 2003 | J. Endocrinol. | pmid:12697042 |
| Nakano M et al. | Inhibitory effect of titanium particles on osteoclast formation generated by treatment of mouse bone marrow cells with PGE2. | 2003 | Oral Dis | pmid:12657033 |
| Ra JS et al. | Osteoprotegerin inhibits proliferation of myeloid progenitor cells. | 2003 | J. Hematother. Stem Cell Res. | pmid:12662434 |
| Szalay F et al. | High serum osteoprotegerin and low RANKL in primary biliary cirrhosis. | 2003 | J. Hepatol. | pmid:12663228 |
| Okada Y et al. | Impaired osteoclast formation in bone marrow cultures of Fgf2 null mice in response to parathyroid hormone. | 2003 | J. Biol. Chem. | pmid:12665515 |
| Yu Q et al. | Cooperation of TNF family members CD40 ligand, receptor activator of NF-kappa B ligand, and TNF-alpha in the activation of dendritic cells and the expansion of viral specific CD8+ T cell memory responses in HIV-1-infected and HIV-1-uninfected individuals. | 2003 | J. Immunol. | pmid:12574344 |
| Rifas L et al. | Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts. | 2003 | J. Cell. Biochem. | pmid:12577299 |
| Gordeladze JO and Reseland JE | A unified model for the action of leptin on bone turnover. | 2003 | J. Cell. Biochem. | pmid:12577304 |
| Lubberts E et al. | IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance. | 2003 | J. Immunol. | pmid:12594294 |
| Kato I et al. | TRANCE together with IL-7 induces pre-B cells to proliferate. | 2003 | Eur. J. Immunol. | pmid:12548564 |
| Sordillo EM and Pearse RN | RANK-Fc: a therapeutic antagonist for RANK-L in myeloma. | 2003 | Cancer | pmid:12548579 |
| Oyajobi BO and Mundy GR | Receptor activator of NF-kappaB ligand, macrophage inflammatory protein-1alpha, and the proteasome: novel therapeutic targets in myeloma. | 2003 | Cancer | pmid:12548580 |
| Croucher PI et al. | Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease. | 2003 | Cancer | pmid:12548581 |
| Lipton A | Bisphosphonates and metastatic breast carcinoma. | 2003 | Cancer | pmid:12548585 |
| Demers LM | Bone markers in the management of patients with skeletal metastases. | 2003 | Cancer | pmid:12548589 |
| Body JJ et al. | A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases. | 2003 | Cancer | pmid:12548591 |
| Liu JZ et al. | [The OPG/RANKL/RANK system and bone resorptive disease]. | 2003 | Sheng Wu Gong Cheng Xue Bao | pmid:15971575 |
| Liu JZ et al. | [Construction and biological activity study of human osteoprotegerin expressing adenoviral system]. | 2003 | Sheng Wu Gong Cheng Xue Bao | pmid:15969033 |
| Chagraoui H et al. | Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO. | 2003 | Blood | pmid:12506018 |
| Lee Y et al. | Differences in the cytokine profiles associated with prostate cancer cell induced osteoblastic and osteolytic lesions in bone. | 2003 | J. Orthop. Res. | pmid:12507581 |
| Sabokbar A et al. | Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis. | 2003 | J. Orthop. Res. | pmid:12507582 |
| Elhasid R et al. | Familial severe congenital neutropenia associated with infantile osteoporosis: a new entity. | 2003 | Am. J. Hematol. | pmid:12508266 |
| Haynes DR et al. | Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls. | 2003 | Rheumatology (Oxford) | pmid:12509625 |
| Rude RK et al. | Magnesium deficiency: effect on bone and mineral metabolism in the mouse. | 2003 | Calcif. Tissue Int. | pmid:12370796 |